|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/5078 | (2013.01) | ||
| A61K 31/4748 | (2006.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 31/4748 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/5047 | (2013.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61P 25/08 | (2006.01) |
| (11) | Number of the document | 3624779 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18802748.6 |
| Date of filing the European patent application | 2018-05-21 | |
| (97) | Date of publication of the European application | 2020-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/033722 |
| Date | 2018-05-21 |
| (87) | Number | WO 2018/213838 |
| Date | 2018-11-22 |
| (30) | Number | Date | Country code |
| 201762508554 P | 2017-05-19 | US |
| (72) |
COLLINS, Stephen D. , US
GOLDSTEIN, Peter , US
JOHNSTONE, Joshua T. , US
|
| (73) |
Biscayne Neurotherapeutics, Inc. ,
9715 Key West Avenue, Rockville, MD 20850,
US
|
| (54) | MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF HUPERZINE AND METHODS OF USING THE SAME |
| MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF HUPERZINE AND METHODS OF USING THE SAME |